BACKGROUND
MYBPC3 truncating variants (MYBPC3tv) represent the most common genetic substrate in hypertrophic cardiomyopathy, yet carriers show substantial phenotypic variability despite a shared mechanism of haploinsufficiency. The contribution of additional genetic variants to this variability remains incompletely def...
S. Garcia-Hernandez, L. de la Higuera Romero, J. Larrañaga-Moreira et al.· Circulation Genomic and Prec...· 0 citations
Genetic testing informs risk stratification in dilated cardiomyopathy (DCM), yet likely pathogenic/pathogenic (LP/P) variants are identified in only one-third of patients. Gene-elusive DCM may confer a lower risk of adverse clinical events than genotype-positive disease, but remains poorly characterised. Left bun...
D. Cannie, A. Bakalakos, P. Syrris et al.· European Heart Journal· 0 citations
In this large HCM cohort, variant re-evaluation resulted in a modest but clinically relevant reclassification of genetic variants, consistent with consolidation of locus-specific evidence and important given their association with adverse outcomes, despite modest hypertrophy.
A. Bakalakos, R. Lorca, A. Protonotarios et al.· European Journal of Human Ge...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.